Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Non-Current Debt (2019 - 2025)

Viemed Healthcare's Non-Current Debt history spans 7 years, with the latest figure at $11.3 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 214.6% year-over-year to $11.3 million; the TTM value through Dec 2025 reached $11.3 million, up 214.6%, while the annual FY2025 figure was $11.3 million, 214.6% up from the prior year.
  • Non-Current Debt reached $11.3 million in Q4 2025 per VMD's latest filing, down from $19.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $19.6 million in Q3 2025 to a low of $3.5 million in Q2 2025.
  • Average Non-Current Debt over 5 years is $6.5 million, with a median of $4.6 million recorded in 2021.
  • The largest YoY upside for Non-Current Debt was 436.58% in 2025 against a maximum downside of 60.24% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $4.3 million in 2021, then fell by 3.48% to $4.2 million in 2022, then soared by 44.42% to $6.0 million in 2023, then plummeted by 40.2% to $3.6 million in 2024, then surged by 214.6% to $11.3 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Non-Current Debt are $11.3 million (Q4 2025), $19.6 million (Q3 2025), and $3.5 million (Q2 2025).